100 related articles for article (PubMed ID: 8797237)
21. Effect of ritanserin on the interaction of amfonelic acid and neuroleptic-induced striatal dopamine metabolism.
Brougham LR; Conway PG; Ellis DB
Neuropharmacology; 1991 Oct; 30(10):1137-40. PubMed ID: 1684649
[TBL] [Abstract][Full Text] [Related]
22. Local infusion of the serotonin antagonists ritanserin or ICS 205,930 increases in vivo dopamine release in the rat medial prefrontal cortex.
Pehek EA
Synapse; 1996 Sep; 24(1):12-8. PubMed ID: 9046072
[TBL] [Abstract][Full Text] [Related]
23. Striatal dopamine D1 and D2 receptors: widespread influences on methamphetamine-induced dopamine and serotonin neurotoxicity.
Gross NB; Duncker PC; Marshall JF
Synapse; 2011 Nov; 65(11):1144-55. PubMed ID: 21584865
[TBL] [Abstract][Full Text] [Related]
24. Receptor binding of N-(methyl-11C) clozapine in the brain of rhesus monkey studied by positron emission tomography (PET).
Hartvig P; Eckernäs SA; Lindström L; Ekblom B; Bondesson U; Lundqvist H; Halldin C; Någren K; Långström B
Psychopharmacology (Berl); 1986; 89(2):248-52. PubMed ID: 3088645
[TBL] [Abstract][Full Text] [Related]
25. Neonatal dopamine depletion reveals a synergistic mechanism of mRNA regulation that is mediated by dopamine(D1) and serotonin(2) receptors and is targeted to tachykinin neurons of the dorsomedial striatum.
Campbell BM; Gresch PJ; Walker PD
Neuroscience; 2001; 105(3):671-80. PubMed ID: 11516832
[TBL] [Abstract][Full Text] [Related]
26. 5-HT2 receptor regulation of acetylcholine release induced by dopaminergic stimulation in rat striatal slices.
Ramírez MJ; Cenarruzabeitia E; Lasheras B; Del Rio J
Brain Res; 1997 May; 757(1):17-23. PubMed ID: 9200494
[TBL] [Abstract][Full Text] [Related]
27. Neurochemical effects of chronic co-administration of ritanserin and haloperidol: comparison with clozapine effects.
Lappalainen J; Hietala J; Koulu M; Syvälahti E
Eur J Pharmacol; 1990 Nov; 190(3):403-7. PubMed ID: 2125564
[TBL] [Abstract][Full Text] [Related]
28. Equivalent occupancy of dopamine D1 and D2 receptors with clozapine: differentiation from other atypical antipsychotics.
Tauscher J; Hussain T; Agid O; Verhoeff NP; Wilson AA; Houle S; Remington G; Zipursky RB; Kapur S
Am J Psychiatry; 2004 Sep; 161(9):1620-5. PubMed ID: 15337652
[TBL] [Abstract][Full Text] [Related]
29. Systemic administration of amperozide, a new atypical antipsychotic drug, preferentially increases dopamine release in the rat medial prefrontal cortex.
Nomikos GG; Iurlo M; Andersson JL; Kimura K; Svensson TH
Psychopharmacology (Berl); 1994 Jun; 115(1-2):147-56. PubMed ID: 7862887
[TBL] [Abstract][Full Text] [Related]
30. Clozapine, SCH 23390 and alpha-flupenthixol but not haloperidol attenuate acute phencyclidine-induced disruption of conditional discrimination performance.
Dunn MJ; Killcross S
Psychopharmacology (Berl); 2007 Mar; 190(4):403-14. PubMed ID: 17237918
[TBL] [Abstract][Full Text] [Related]
31. Age-related changes of dopamine D1-like and D2-like receptor binding in the F344/N rat striatum revealed by positron emission tomography and in vitro receptor autoradiography.
Suzuki M; Hatano K; Sakiyama Y; Kawasumi Y; Kato T; Ito K
Synapse; 2001 Sep; 41(4):285-93. PubMed ID: 11494399
[TBL] [Abstract][Full Text] [Related]
32. MDMA-evoked changes in [11C]raclopride and [11C]NMSP binding in living pig brain.
Rosa-Neto P; Gjedde A; Olsen AK; Jensen SB; Munk OL; Watanabe H; Cumming P
Synapse; 2004 Sep; 53(4):222-33. PubMed ID: 15266554
[TBL] [Abstract][Full Text] [Related]
33. Time course of central nervous dopamine-D2 and 5-HT2 receptor blockade and plasma drug concentrations after discontinuation of quetiapine (Seroquel) in patients with schizophrenia.
Gefvert O; Bergström M; Långström B; Lundberg T; Lindström L; Yates R
Psychopharmacology (Berl); 1998 Jan; 135(2):119-26. PubMed ID: 9497016
[TBL] [Abstract][Full Text] [Related]
34. Localization of serotonin 5-HT2 receptors in living human brain by positron emission tomography using N1-([11C]-methyl)-2-Br-LSD.
Wong DF; Lever JR; Hartig PR; Dannals RF; Villemagne V; Hoffman BJ; Wilson AA; Ravert HT; Links JM; Scheffel U
Synapse; 1987; 1(5):393-8. PubMed ID: 2905532
[TBL] [Abstract][Full Text] [Related]
35. Alterations in the level of neurotransmitters associated with the chronic treatment of antipsychotic drugs.
Wasti A; Siddiqui NA
J Pak Med Assoc; 2010 Aug; 60(8):628-32. PubMed ID: 20726191
[TBL] [Abstract][Full Text] [Related]
36. Use of LC/MS to assess brain tracer distribution in preclinical, in vivo receptor occupancy studies: dopamine D2, serotonin 2A and NK-1 receptors as examples.
Chernet E; Martin LJ; Li D; Need AB; Barth VN; Rash KS; Phebus LA
Life Sci; 2005 Dec; 78(4):340-6. PubMed ID: 16139310
[TBL] [Abstract][Full Text] [Related]
37. D2-dopamine receptor specific brain uptake of carbon-11-labeled YM-09151-2.
Hatano K; Ishiwata K; Kawashima K; Hatazawa J; Itoh M; Ido T
J Nucl Med; 1989 Apr; 30(4):515-22. PubMed ID: 2567779
[TBL] [Abstract][Full Text] [Related]
38. Gradients of dopamine D1- and D2/3-binding sites in the basal ganglia of pig and monkey measured by PET.
Rosa-Neto P; Doudet DJ; Cumming P
Neuroimage; 2004 Jul; 22(3):1076-83. PubMed ID: 15219579
[TBL] [Abstract][Full Text] [Related]
39. Binding characteristics and sensitivity to endogenous dopamine of [11C]-(+)-PHNO, a new agonist radiotracer for imaging the high-affinity state of D2 receptors in vivo using positron emission tomography.
Ginovart N; Galineau L; Willeit M; Mizrahi R; Bloomfield PM; Seeman P; Houle S; Kapur S; Wilson AA
J Neurochem; 2006 May; 97(4):1089-103. PubMed ID: 16606355
[TBL] [Abstract][Full Text] [Related]
40. [123I]IBZM SPECT in patients treated with typical and atypical neuroleptics: relationship to drug plasma levels and extrapyramidal side effects.
Schlösser R; Schlegel S; Hiemke C; Nickel O; Bockisch A; Rao ML; Hahn K
Psychiatry Res; 1997 Sep; 75(2):103-14. PubMed ID: 9351492
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
